ATE462698T1 - Verfahren zur synthese von imidazolaminosäurederivaten und verwandten verbindungen - Google Patents

Verfahren zur synthese von imidazolaminosäurederivaten und verwandten verbindungen

Info

Publication number
ATE462698T1
ATE462698T1 AT05766686T AT05766686T ATE462698T1 AT E462698 T1 ATE462698 T1 AT E462698T1 AT 05766686 T AT05766686 T AT 05766686T AT 05766686 T AT05766686 T AT 05766686T AT E462698 T1 ATE462698 T1 AT E462698T1
Authority
AT
Austria
Prior art keywords
synthesis
imidazolaminosic
acid derivatives
related compounds
compounds
Prior art date
Application number
AT05766686T
Other languages
English (en)
Inventor
Dennis Hlasta
Craig Zificsak
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE462698T1 publication Critical patent/ATE462698T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05766686T 2005-06-29 2005-06-29 Verfahren zur synthese von imidazolaminosäurederivaten und verwandten verbindungen ATE462698T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/023048 WO2007005000A1 (en) 2005-06-29 2005-06-29 Method of synthesis of imidazole-amino acid derivatives and related compounds

Publications (1)

Publication Number Publication Date
ATE462698T1 true ATE462698T1 (de) 2010-04-15

Family

ID=35922707

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05766686T ATE462698T1 (de) 2005-06-29 2005-06-29 Verfahren zur synthese von imidazolaminosäurederivaten und verwandten verbindungen

Country Status (7)

Country Link
EP (1) EP1904465B1 (de)
JP (1) JP4866905B2 (de)
AT (1) ATE462698T1 (de)
BR (1) BRPI0520406B8 (de)
CA (1) CA2613047C (de)
DE (1) DE602005020367D1 (de)
WO (1) WO2007005000A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7185468B2 (en) 2002-10-31 2007-03-06 Jeld-Wen, Inc. Multi-layered fire door and method for making the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360811A (en) * 1990-03-13 1994-11-01 Hoechst-Roussel Pharmaceuticals Incorporated 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds as anti-inflammatory agents
CZ20021161A3 (cs) * 1999-10-14 2002-08-14 The Procter & Gamble Company Beta -disubstituované inhibitory metaloproteináz

Also Published As

Publication number Publication date
EP1904465A1 (de) 2008-04-02
BRPI0520406A2 (pt) 2009-05-05
CA2613047A1 (en) 2007-01-11
DE602005020367D1 (de) 2010-05-12
JP4866905B2 (ja) 2012-02-01
JP2009501152A (ja) 2009-01-15
WO2007005000A1 (en) 2007-01-11
EP1904465B1 (de) 2010-03-31
BRPI0520406B1 (pt) 2020-12-29
CA2613047C (en) 2013-10-22
BRPI0520406B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
SI1711481T2 (sl) Postopek za pripravo 2-aminotiazoli-5-aromatiäśnih karboksamidov kot kinazni inhibitorji
EA201000149A1 (ru) Производные 1-фенил-2-пиридинилалкиловых спиртов в качестве ингибиторов фосфодиэстераз
ATE480525T1 (de) Neues verfahren zur synthese von 2- aminooxazolverbindungen
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
NO20076597L (no) Fremgangsmater for fremstilling av 4-(bifenylyl)azetidin-2-one fosforsyrer
SI2091948T1 (sl) Novi inhibitorji glutaminil ciklaze
EA200800728A1 (ru) Полиморфы бензоатной соли 2-[[6-[(3r)-3-амино-1-пиперидинил]-3,4-дигидро-3-метил-2,4-диоксо-1(2н)-пиримидинил]метил]бензонитрила и способы их применения
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
EA200601391A1 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
DE602005027388D1 (de) Malonsäureamidderivate als inhibitoren von g-sekretase zur behandlung von alzheimer-krankheit
EP1817312A4 (de) Makrozyklische aminiopyridyl-beta-sekretase-hemmer zur behandlung von morbus alzheimer
ATE532516T1 (de) Verfahren zur synthese von glyt-1-hemmern
ATE538796T1 (de) Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit
BRPI0615691A8 (pt) Método para a preparação de 6-((3s,4r)-4-(4-amino-5-cloro-2-metoxibenzamido)-3-metoxipiperidin-1-il) hexanoato de (r)-quinuclidin-3-ila ou sal do mesmo
DE602006019870D1 (de) Verfahren zur synthese von triazolen
ATE447567T1 (de) Verfahren zur herstellung von tryptase- inhibitoren
ATE493110T1 (de) Kosmetische zusammensetzung zur stimulierung der synthese der proteine der basalmembran
ATE495158T1 (de) Substituierte tetrahydroisochinoline als mmp- inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
DE602005020367D1 (de) Verfahren zur synthese von imidazolaminosäurederivaten und verwandten verbindungen
ATE529413T1 (de) Verfahren zur synthese von aryloxydiaminopyrimidinen
ATE528312T1 (de) Verfahren zur synthese von makroliden
DE602004017023D1 (de) Heterocyclische peptidylketonderivate und herstellungsverfahren
DE602007007773D1 (de) Verfahren zur synthese von ibandronat-natrium

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties